Cynthia J Leveille

Title: Cynthia J Leveille: Innovator in Dystrophin-Associated Protein Research

Introduction

Cynthia J Leveille is a prominent inventor based in Iowa City, IA (US). She has made significant contributions to the field of biotechnology, particularly in the development of antibodies and nucleic acids related to dystrophin-associated proteins. With a total of 2 patents, her work has implications for therapeutic methods addressing muscular dystrophy.

Latest Patents

Cynthia's latest patents include innovative methods for the preparation of polyclonal and monoclonal antibodies that specifically bind to a 43 kDa dystrophin-associated protein. The first patent details methods involving the administration of a specific peptide to stimulate an immune response, which is crucial for the development of effective antibodies. The second patent focuses on substantially pure nucleic acid sequences encoding portions of dystrophin-associated proteins, which can be utilized in DNA expression constructs for therapeutic applications.

Career Highlights

Cynthia is affiliated with the University of Iowa Research Foundation, where she conducts her research. Her work has been instrumental in advancing the understanding of dystrophin-associated proteins and their role in muscular dystrophy.

Collaborations

Cynthia collaborates with notable researchers in her field, including Kevin P Campbell and James M Ervasti. Their combined expertise enhances the impact of their research on muscular dystrophy and related conditions.

Conclusion

Cynthia J Leveille's innovative research and patents contribute significantly to the field of biotechnology, particularly in developing therapeutic solutions for muscular dystrophy. Her work exemplifies the importance of collaboration and innovation in scientific research.